✦ LIBER ✦

Binding of a tritiated inverse agonist to cannabinoid CB1 receptors is increased in patients with schizophrenia

✍ Scribed by Kimberly J. Jenko; Jussi Hirvonen; Ioline D. Henter; Kacey B. Anderson; Sami S. Zoghbi; Thomas M. Hyde; Amy Deep-Soboslay; Robert B. Innis; Joel E. Kleinman

Book ID: 119366299
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 217 KB
Volume: 141
Category: Article
ISSN: 0920-9964
DOI: 10.1016/j.schres.2012.07.021

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Selective antagonist [3H]SR141716A bindi

Selective antagonist [3H]SR141716A binding to cannabinoid CB1 receptors is increased in the anterior cingulate cortex in schizophrenia

✍ Katerina Zavitsanou; Therese Garrick; Xu Feng Huang 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 223 KB

F200A substitution in the third transmem

F200A substitution in the third transmembrane helix of human cannabinoid CB1 receptor converts AM2233 from receptor agonist to inverse agonist

✍ Chun-Pyn Shen; Jing Chen Xiao; Helen Armstrong; William Hagmann; Tung M. Fong 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 298 KB

EFFECTS OF TARANABANT, A NOVEL CANNABINO

EFFECTS OF TARANABANT, A NOVEL CANNABINOID 1 RECEPTOR (CB-1R) INVERSE AGONIST, ON WEIGHT REDUCTION IN OBESE PATIENTS OVER 12 WEEKS

✍ Carr, R.; Erondu, N.; Gonzalez, C.; Gumbiner, B.; Musser, B.; Lu, K.; Capece, R. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 102 KB

PET Imaging of cannabinoid CB1 type rece

PET Imaging of cannabinoid CB1 type receptors in healthy humans and patients with schizophrenia using [11C]OMAR

✍ Dean F. Wong; H. Kuwabara; A. Horti; A. Kumar; J. Brasic; W. Ye; M. Alexander; V 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 57 KB

A one-year study to assess the safety an

A one-year study to assess the safety and efficacy of the CB1R inverse agonist taranabant in overweight and obese patients with type 2 diabetes

✍ M. S. Kipnes; P. Hollander; K. Fujioka; I. Gantz; T. Seck; N. Erondu; Y. Shentu; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 687 KB

The decrease of dopamine D2/D3 receptor

The decrease of dopamine D2/D3 receptor densities in the putamen and nucleus caudatus goes parallel with maintained levels of CB1 cannabinoid receptors in Parkinson's disease: A preliminary autoradiographic study with the selective dopamine D2/D3 antagonist [3H]raclopride and the novel CB1 inverse agonist [125I]SD7015

✍ Szabolcs Farkas; Katalin Nagy; Zhisheng Jia; Tibor Harkany; Miklós Palkovits; Se 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 745 KB